Nath Bio-Genes (India) Limited
Symbool: NATHBIOGEN.NS
NSE
195
INRMarktprijs vandaag
9.0886
Koers/Winst Verhouding
2.0302
Koers/Winst Groei Verhouding
3.71B
MRK Kapitalisatie
- 0.02%
DIV Rendement
Nath Bio-Genes (India) Limited (NATHBIOGEN-NS) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 2089.2 | 41.7 | 292.1 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 1709.3 | 0.2 | 0 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 1033.6 | 2456.6 | 2683.8 | ||||||||||||
balance-sheet.row.inventory | 0 | 2078.5 | 2203.4 | 2263 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 7 | 0 | 0 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 5208.3 | 4701.7 | 5238.9 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2339.6 | 2328.5 | 2333 | ||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 104.2 | 120.3 | 136.2 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 50.5 | 50.5 | 50.5 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 218.1 | 136.5 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 225.4 | 0 | 0 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 2719.7 | 2717.4 | 2656.2 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.account-payables | 0 | 277.4 | 550.9 | 452.3 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 1048.1 | 922.9 | 959.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 2.8 | 8.9 | 25.3 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 4 | 6.6 | 6.5 | ||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 830.4 | 63.6 | 0 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 31.7 | 32.8 | 32.3 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-liab | 0 | 2196.2 | 1999.4 | 1762.3 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 190 | 190 | 190 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 4056.6 | 3744.7 | 4456.1 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 150.1 | 149.9 | 151.6 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 1335 | 1335 | 1335 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5731.7 | 5419.7 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 7928 | 7419.1 | 7895.1 | ||||||||||||
balance-sheet.row.minority-interest | 0 | -0.2 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 0 | 5731.5 | 5419.6 | 6132.8 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 50.5 | 50.6 | 50.5 | ||||||||||||
balance-sheet.row.total-debt | 0 | 1052.1 | 929.6 | 965.7 | ||||||||||||
balance-sheet.row.net-debt | 0 | 672.2 | 887.9 | 673.6 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 361.6 | -633.9 | 567.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 30.1 | 30.8 | 28.2 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | -98.1 | -180.7 | -651.3 | |||||||||||
cash-flows.row.account-receivables | 0 | -118.8 | 210.2 | -20.6 | |||||||||||
cash-flows.row.inventory | 0 | 125 | 59.6 | -219.9 | |||||||||||
cash-flows.row.account-payables | 0 | -150.5 | 199.9 | -229.7 | |||||||||||
cash-flows.row.other-working-capital | 0 | 46.2 | -650.4 | -181.1 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 90 | 954.2 | 66.7 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 0.5 | 0.7 | 1.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.2 | -0.5 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | -0.5 | -0.7 | -1.5 | |||||||||||
cash-flows.row.other-investing-activites | 0 | -3.4 | 11.7 | 13.7 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -28.8 | -198.7 | -102.8 | |||||||||||
cash-flows.row.debt-repayment | 0 | -122.5 | -78.2 | -252.2 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.dividends-paid | 0 | -38 | -38 | 0 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 143.9 | -106.1 | 416.2 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -16.7 | -222.3 | 164 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.1 | 0 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 338.1 | -250.5 | 72.3 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 380 | 41.7 | 292.2 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 41.8 | 292.2 | 219.8 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 383.7 | 170.5 | 11.1 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -25.5 | -210.2 | -116 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 358.2 | -39.7 | -104.9 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3326.2 | 3012.9 | 2783.6 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1650.8 | 1345.9 | 1239.7 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 1675.4 | 1667 | 1543.9 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 1209.4 | 1208.2 | 1197.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 2860.2 | 2554.1 | 2437 | |||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 0.2 | 10.9 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 5.6 | 1 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -84.8 | -95.7 | -980 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 91.1 | 101.2 | 101.3 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 32.6 | 30.1 | 30.8 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 466 | 457.3 | 345.7 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 381.2 | 363.2 | -633.9 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 19.5 | 11.5 | 39.5 | |||||||||||||
income-statement-row.row.net-income | 0 | 361.7 | 350.1 | -673.4 |
Vaak gestelde vragen
Wat is Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) totale activa?
Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) totale activa is 7927970000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.528.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.121.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.147.
Wat is Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) nettowinst (netto-inkomen)?
De nettowinst is 361697000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 1052123000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 1209402000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.